Budapest, Hungary

Agnes Koracs Nee Palotay

This inventor holds 1 USPTO granted patent. Top assignee: Egyt Gyogyszervegyeszeti Gyar. Active years: 1982.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Agnes Koracs Nee Palotay. Retrieved from https://idiyas.com/inventor/agnes-koracs-nee-palotay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Agnes Koracs Nee Palotay: Innovator in Pharmaceutical Chemistry

Introduction

Agnes Koracs Nee Palotay is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative research and development of new compounds.

Latest Patents

Agnes holds a patent for "Novel dihydro-as-triazino[5,6-c]quinoline derivatives and a process for." This patent discloses new compounds of specific formulae or pharmaceutically effective salts, wherein R can be hydrogen, C1-12 alkyl, or phenyl with various substituents. Her work in this area showcases her expertise and commitment to advancing pharmaceutical science.

Career Highlights

Agnes is associated with Egyt Gyogyszervegyeszeti Gyar, where she has been instrumental in developing innovative pharmaceutical solutions. Her dedication to research and development has positioned her as a key figure in her field.

Collaborations

Agnes has collaborated with notable colleagues, including Edit Berenyi Nee Poldermann and Peter Gorog. These partnerships have further enhanced her research efforts and contributed to her success in the industry.

Conclusion

Agnes Koracs Nee Palotay is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. Her contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…